Therapy dogs benefit adult patients with cancer receiving chemo, radiation
the ONA take:
According to a new study published in the Journal of Community and Supportive Oncology, researchers at Mount Sinai Beth Israel in New York City, New York, have found that therapy dogs improve the emotional well-being of some patients with cancer who are undergoing concomitant chemotherapy and radiotherapy.
For the study, researchers enrolled patients with gastrointestinal cancer or head and neck cancer who were undergoing intensive multi-modal chemoradiation. They found that these patients experienced increases in quality of life and emotional well-being when they were visited by certified therapy dogs during their treatment course.
Even when patients experienced significant declines in both functional and physical well-being during their treatment course, their emotional well-being significantly improved when visited by the therapy dogs. Some patients reported that they would have discontinued their treatment if they were not receiving visits from the therapy dog and volunteer handler.
The findings suggest that therapy dogs are a creative and valuable intervention that can be utilized to improve the emotional well-being of patients receiving concomitant chemotherarpy and radiation.
Therapy dogs improve the emotional well-being of some patients with cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|